Godavari Drugs Ltd — Important, 12-02-2026: Company Update

Godavari Drugs has published its financial results for the quarter and nine months ended December 31, 2025. The Board reviewed and approved these results. For the quarter, total income from operations was ₹22.20 Cr, with a net profit after tax of ₹0.76 Cr, and basic EPS of ₹1.01. For the nine-month period, total income reached ₹73.31 Cr, net profit after tax was ₹2.80 Cr, and basic EPS stood at ₹3.72. These figures offer key insights into the company's financial health and performance for investors.